Antigenic and Genetic Characteristics of Zoonotic Influenza Viruses and Development of Candidate Vaccine Viruses for Pandemic Preparedness
Source: World Health Organization (WHO). Published: 2/21/2019. This 10-page document summarizes the genetic and antigenic characteristics of recent zoonotic influenza viruses and related viruses circulating in animals that are relevant to influenza candidate vaccine virus updates. Zoonotic influenza viruses continue to be identified and evolve both genetically and antigenically, leading to the need for additional candidate vaccine viruses for pandemic preparedness purposes. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - February 21, 2019 Category: International Medicine & Public Health Source Type: news

Preventing parasites with new vaccines
Preventing parasites in poultry, cattle and other livestock is a major concern for Europe's farmers. As current treatments prove less effective or desirable, EU-funded scientists are working on new vaccines to keep animals healthy and safeguard our food supply. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - February 21, 2019 Category: Research Source Type: news

Reverse Engineering for SDGs
Dr. Kakoli Ghosh, Strategic Program on Sustainable Agriculture Management Team, FAO Ms. Loreta Zdanovaite, Partnerships Officer, Division of Partnerships, FAOBy Kakoli Ghosh and Loreta ZdanovaiteROME, Feb 20 2019 (IPS)When young people from small towns and villages seek higher education they have to usually migrate to big cities leaving their local communities behind. On completion of their degree from the Universities, they generally prefer staying in cities, in search of a good job and a successful career. Though this is a standard practice, it is also a case of lost opportunities, especially for students who pursue high...
Source: IPS Inter Press Service - Health - February 20, 2019 Category: International Medicine & Public Health Authors: Kakoli Ghosh and Loreta Zdanovaite Tags: Africa Development & Aid Economy & Trade Education Environment Featured Food & Agriculture Global Green Economy Headlines Health Labour Natural Resources Poverty & SDGs TerraViva United Nations Trade & Investment Water & Sa Source Type: news

Health Officials Are Worried That ‘Zombie Deer Disease’ Could Someday Spread to Humans
Officials are worried that a prion disease spreading among deer in the U.S. may someday threaten the health of humans. Chronic wasting disease (CWD), which is nicknamed “zombie deer disease,” gets its name from a range of symptoms. For deer, elk and moose, these include stumbling, listlessness, drooling and rapid weight loss. The fatal disease degrades the brains, spines and bodies of the animals it infects, and there are no known treatments or vaccines. No cases of CWD have been recorded in humans. It has not even been definitely proven that humans can be infected by CWD, though some research has suggested it&...
Source: TIME: Health - February 19, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime public health Source Type: news

Is this why vaccine pushers are such mean people? New vaccine study concludes that they cause antisocial behavior
(Natural News) Vaccine skepticism is heavily discouraged by the establishment, but research discrediting the myth of vaccine safety continues to pile up. A newly published study has found a link between vaccination and changes to the brain and behavior in animals. Among the results, scientist have found that vaccines with aluminum adjuvants can trigger antisocial... (Source: NaturalNews.com)
Source: NaturalNews.com - February 15, 2019 Category: Consumer Health News Source Type: news

Immune stimulant molecule shown to prevent cancer
(University of Louisville) An immune checkpoint molecule developed for cancer immunotherapy also protects against future development of multiple types of cancer when administered by itself. The recombinant protein molecule SA-4-1BBL has been used to enhance the therapeutic efficacy of cancer vaccines with success in pre-clinical animal models. Surprisingly, when the researchers treated normal, healthy mice with SA-4-1BBL alone, the mice were protected when the researchers later exposed them to different types of tumor cells. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 15, 2019 Category: International Medicine & Public Health Source Type: news

Researchers Find Way For Chickens To Lay Eggs Filled With Cancer-Killing Drugs
BOSTON (CBS) – Researchers in Scotland say they have found a way to have chickens lay eggs filled with medicine. It’s a method that could make some drugs much more affordable. Scientists at The University of Edinburgh have genetically modified the birds to produce human proteins in their eggs that boost the immune system. Now, the chickens are laying eggs containing cancer-killing drugs. Researchers in Scotland have genetically modified chickens to produce human proteins in their eggs (WBZ-TV) “In the past, making these transgenic animals has been very inefficient very expensive and difficult,” says...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 28, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Seen On WBZ-TV Cancer Dr. Mallika Marshall Source Type: news

New precision medicine procedure fights cancer, advances treatment for pets and humans
(University of Missouri-Columbia) In a first-of-its-kind study, scientists at the University of Missouri have helped advance a patient-specific, precision medicine treatment for bone cancer in dogs. By creating a vaccine from a dog's own tumor, scientists worked with ELIAS Animal Health to target specific cancer cells and avoid the toxic side effects of chemotherapy, while also opening the door for future human clinical trials. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 28, 2019 Category: International Medicine & Public Health Source Type: news

Launch of first veterinary vaccines produced in China
Boehringer Ingelheim launches first veterinary vaccines produced in ChinaThe first local manufacturing plant, wholly-owned by a multinational animal health company, focuses on the China swine marketThe Taizhou plant will produce PRRS vaccines and supply them locallyThe company delivers on its long-term ‘in China, for China’ commitment while accelerating its localisation strategy (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - January 24, 2019 Category: Research Source Type: news

A Mysterious Company Claims to Sell Sneeze-Filled Tissues for $80. Is It Real?
The package appeared one day, unbidden, on the desk of a TIME writer. Inside was a slick white box that housed a petri dish sealed with gold tape. In the dish was a crumpled tissue—and inside the tissue were, allegedly, the germs of a sick person who had sneezed into it. Vaev Tissue, the only product of a new startup based in Los Angeles, costs $79.99, according to the company’s website. Its sole purpose is to give the user a cold virus. “We believe using a tissue that carries a human sneeze is safer than needles or pills,” read the note that came with the product, written by the founder of the comp...
Source: TIME: Health - January 18, 2019 Category: Consumer Health News Authors: Mandy Oaklander Tags: Uncategorized public health Source Type: news

Anti-Opioid Vaccine Shows Promise in Mice
THURSDAY, Dec. 13, 2018 -- A vaccine that might help combat the opioid epidemic has performed well in early animal testing, researchers report. The vaccine contains antibodies that are effective against several synthetic opioids, including fentanyl... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 13, 2018 Category: General Medicine Source Type: news

Shameless vaccine promoters now using zoo animals for propaganda: Baby gorilla "gets his flu shot"
(Natural News) As more Americans are wising up to the sham of vaccination, Big Pharma and the mainstream media are conjuring up pro-vaccine propaganda whenever they can. Now, the vaccine industry is stooping so low as to use zoo animals to fuel their  agenda. And at the Smithsonian’s National Zoo, a baby gorilla was just... (Source: NaturalNews.com)
Source: NaturalNews.com - December 12, 2018 Category: Consumer Health News Source Type: news

Alexa now will help take care of your pet
VCA Animal Hospitals has teamed with Amazon.com Inc. to help pet owners book veterinarian appointments and get healthcare reminders using the Alexa voice command system. Alexa users can now enable the skill after linking their device to a VCA account online. They then can open the skill by saying: "Alexa, open VCA;” "Alexa, ask VCA when my pet is due for vaccines;" or "Alexa, ask VCA to book an appointment for my pet.” Los Angeles-based VCA, which operates mo re than 850 small animal veterinary… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 7, 2018 Category: Pharmaceuticals Authors: I-Chun Chen Source Type: news

Mars-owned animal hospital teams with Amazon ’s Alexa to book vet appointments
VCA Animal Hospitals has teamed with Amazon.com Inc. to help pet owners book veterinarian appointments and get health care reminders using the Alexa voice command system. Alexa users can now enable the skill after linking their device to a VCA account online. They then can open the skill by saying: "Alexa, open VCA;” "Alexa, ask VCA when my pet is due for vaccines;" or "Alexa, ask VCA to book an appointment for my pet.” Los Angeles-based VCA, which operates mo re than 850 small animal veterinary… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 6, 2018 Category: Pharmaceuticals Authors: I-Chun Chen Source Type: news

Mars-owned animal hospital teams with Amazon ’s Alexa to book vet appointments
VCA Animal Hospitals has teamed with Amazon.com Inc. to help pet owners book veterinarian appointments and get health care reminders using the Alexa voice command system. Alexa users can now enable the skill after linking their device to a VCA account online. They then can open the skill by saying: "Alexa, open VCA;” "Alexa, ask VCA when my pet is due for vaccines;" or "Alexa, ask VCA to book an appointment for my pet.” Los Angeles-based VCA, which operates mo re than 850 small animal veterinary… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 6, 2018 Category: Biotechnology Authors: I-Chun Chen Source Type: news

New HIV vaccine candidate shows promise in animal tests
Researchers may have cleared another hurdle to developing an HIV vaccine, as one potential candidate has shown promise in early tests with animals. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 26, 2018 Category: Consumer Health News Source Type: news

Alzheimer's Vaccine Shows Promise in Mice
MONDAY, Nov. 26, 2018 -- An experimental Alzheimer's disease vaccine shows promise in animal tests, and researchers say it could have the potential to reduce dementia cases by half. In mice created to develop Alzheimer's, the vaccine triggered an... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 26, 2018 Category: General Medicine Source Type: news

Scripps Research scientists unveil promising new HIV vaccine strategy
(Scripps Research Institute) A new candidate HIV vaccine from Scripps Research surmounts technical hurdles that stymied previous vaccine efforts, and stimulates a powerful anti-HIV antibody response in animal tests. The new vaccine strategy, described in a paper on Nov. 23 in Science Advances, is based on the HIV envelope protein, Env. This complex, shape-shifting molecule has been notoriously difficult to produce in vaccines in a way that induces useful immunity to HIV. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 26, 2018 Category: International Medicine & Public Health Source Type: news

Engineering vaccines to protect farm animals from infection
An EU-funded project is using synthetic biology techniques to design broad-spectra vaccines against mycoplasmas and viral infections in farm animals. By designing a growth medium without animal components and developing a platform to engineer new vaccines, the project will give the EU livestock industry a much-needed boost. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - November 21, 2018 Category: Research Source Type: news

Treatment for canine leishmaniasis exists in Brazilian vaccine
(Morris Animal Foundation) A vaccine used to prevent dogs from contracting the deadly, parasitic disease canine leishmaniasis also can be used to treat currently infected dogs, found Morris Animal Foundation-funded researchers at the University of Iowa, providing a new avenue of treatment for millions of infected dogs globally. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 14, 2018 Category: International Medicine & Public Health Source Type: news

Vaccine protects animals against anthrax and plague
Scientists engineered a vaccine that protects animals from both anthrax and plague. After more development and testing, the approach could be used to combat public health threats. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - October 30, 2018 Category: Consumer Health News Source Type: news

Mouse study suggests vaccine strategy for immunocompromised patients
(University of Illinois at Urbana-Champaign) A study led by Som Nanjappa at the University of Illinois College of Veterinary Medicine identifies a cellular target that may improve efficacy in vaccines designed to protect immunocompromised individuals from potentially deadly opportunistic infections. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 26, 2018 Category: Infectious Diseases Source Type: news

DNA vaccine shows promising, long-term results against Ebola virus
A synthetic DNA vaccine is showing immediate and long-term promising results against the Ebola virus in preclinical animal research. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 10, 2018 Category: Consumer Health News Source Type: news

Inauguration of new global center for veterinary vaccine R & D
Boehringer Ingelheim inaugurates its new global centre for veterinary vaccine R&D in Lyon, France70 million euro investment reinforces the company ’s leading position in the veterinary vaccine marketThe new R&D center of 14,500 square meters is a high-tech facility employing more than 200 employees (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - October 10, 2018 Category: Research Source Type: news

Boehringer Ingelheim is committed to joining forces in the global fight against rabies
The company ’s goal is to bring attention to the serious threat that rabies still poses to animals and humans in many parts of the worldAn estimated 160 people die from rabies every day, 40 per cent of whom are children1Human rabies deaths could be avoided through effective dog vaccination1 (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - September 28, 2018 Category: Research Source Type: news

New vaccine against Bovine Respiratory Disease
: Boehringer Ingelheim reaffirms its focus on preventionBovalto ® Respi Intranasal now registered in most European countries for active immunization of cattle against Bovine Respiratory Syncytial Virus (BRSV) and Bovine Parainfluenza 3 Virus (PI3V), two of the major pathogens involved in Bovine Respiratory Disease (BRD)BRD is one of the most common diseases1 affecting cattle all over the worldBoehringer Ingelheim reaffirms its focus on prevention and animal well-being (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - September 27, 2018 Category: Research Source Type: news

A Vaccine to Prevent Acne? It May Be Possible One Day
TUESDAY, Sept. 4, 2018 -- Acne and adolescence go hand in hand. But researchers say the skin lesions might become a torment of the past if preliminary tests of an experimental vaccine pan out. So far, the vaccine has only been tried on animals and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 4, 2018 Category: General Medicine Source Type: news

First Case Of Dog Flu Confirmed In Massachusetts
BOSTON (CBS) – Dog owners are being urged to vaccinate their pets as the first case of canine flu this year has been confirmed in Massachusetts. A six-month-old poodle was treated and released on Aug. 14 after a two-day stay at the MSPCA’s Angell Animal Medical Center. The MSPCA is urging owners of at-risk dogs to consider vaccinating their pets against the highly contagious virus for added protection. Veterinarians estimate that the the vaccine is about 60 percent effective. Dr. Virginia Sinnott of Angell’s Emergency & Critical Care Unit examines a dog after Massachusetts saw its first confirmed case...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - August 23, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated Local Angell Animal Medical Center dog flu MSPCA Source Type: news

Universal flu vaccine shows shows potential in tests with animals
A candidate for a universal flu vaccine has displayed significant success for various virus strains in animals. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 22, 2018 Category: Consumer Health News Source Type: news

Universal flu vaccine shows potential in tests with animals
A candidate for a universal flu vaccine has displayed significant success for various virus strains in animals. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 22, 2018 Category: Consumer Health News Source Type: news

The World Health Organization Just Declared the Ebola Outbreak in the Democratic Republic of the Congo Is Over
The World Health Organization (WHO) has announced the end of the Ebola outbreak in the Democratic Republic of the Congo (DRC)—the country’s ninth outbreak of the deadly virus—after a total of 53 confirmed and probable cases were reported, including 33 deaths. “The outbreak was contained due to the tireless efforts of local teams, the support of partners, the generosity of donors, and the effective leadership of the Ministry of Health. That kind of leadership, allied with strong collaboration between partners, saves lives,” said WHO Director-General, Dr Tedros Adhanom Ghebreyesus in a statemen...
Source: TIME: Health - July 24, 2018 Category: Consumer Health News Authors: Alexandra Sifferlin Tags: Uncategorized ebola healthytime onetime Source Type: news

Plague vaccine bait -- look who's coming to dinner
(Morris Animal Foundation) Morris Animal Foundation-funded researchers suspected and have now confirmed that plague vaccine bait, designed to protect prairie dogs and assist with recovery efforts of the black-footed ferret, is readily consumed by thousands of small rodents each year but with no apparent ill effect. Results were recently published in the journal EcoHealth. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 19, 2018 Category: International Medicine & Public Health Source Type: news

Cancer Treatment Less Effective in Older Patients
As age increases, so does the risk for cancer. More than half of all cancer cases occur in people over 65. This is especially true for mesothelioma. The average age at diagnosis for pleural mesothelioma — the most common form of the disease — is 69. Despite cancer being more common among the elderly, many cancer treatments work best in younger patients. Researchers now have an idea of why certain cancer treatments don’t work as well in older patients. These important findings were published in June in the medical journal Cell Reports. “While it is clear that primary T cell responses decline in the ...
Source: Asbestos and Mesothelioma News - July 6, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

New & Resurgent Infectious Diseases Can Have Far-reaching Economic Repercussions
DAVID E. BLOOM is the Clarence James Gamble Professor of Economics and Demography, DANIEL CADARETTE is a research assistant, and JP SEVILLA is a research associate, all at Harvard University’s T.H. Chan School of Public Health.By David E. Bloom, Daniel Cadarette and JP SevillaWASHINGTON DC, Jul 3 2018 (IPS)Infectious diseases and associated mortality have abated, but they remain a significant threat throughout the world.We continue to fight both old pathogens, such as the plague, that have troubled humanity for millennia and new pathogens, such as human immunodeficiency virus (HIV), that have mutated or spilled over ...
Source: IPS Inter Press Service - Health - July 3, 2018 Category: International Medicine & Public Health Authors: David E. Bloom and JP Sevilla Tags: Active Citizens Development & Aid Economy & Trade Global Headlines Health TerraViva United Nations Source Type: news

Nigeria:Why Nigeria Cannot Start Producing Vaccines Now - Professor of Virology
[Premium Times] Oyewale Tomori is a professor of virology, educational administrator and former vice chancellor. He is a fellow of the Academy of Science of Nigeria, fellow of the College of Veterinary Surgeons of Nigeria and fellow of the Royal College of Pathologists of the United Kingdom. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 3, 2018 Category: African Health Source Type: news

How a Drug For Pets May Help Prevent Zika and Malaria
Diseases spread by pests like mosquitoes and fleas remain global health problems. To prevent transmission, public health strategy has largely focused on using insecticides or bed nets. Vaccines are also under development for diseases like Zika, but few are approved for use. Now, a new study suggests that medicines already used for pets to protect against fleas and ticks could offer similar protection for humans. In the report, published Monday in the journal Proceedings of the National Academy of Sciences, researchers at the nonprofit drug discovery institute Calibr and TropIQ Health Sciences report that drugs called isoxa...
Source: TIME: Health - July 2, 2018 Category: Consumer Health News Authors: Alexandra Sifferlin Tags: Uncategorized healthytime Innovation Health public health Source Type: news

How a Drug For Pets May Help Prevent Zika and Malaria
Diseases spread by pests like mosquitoes and fleas remain global health problems. To prevent transmission, public health strategy has largely focused on using insecticides or bed nets. Vaccines are also under development for diseases like Zika, but few are approved for use. Now, a new study suggests that medicines already used for pets to protect against fleas and ticks could offer similar protection for humans. In the report, published Monday in the journal Proceedings of the National Academy of Sciences, researchers at the nonprofit drug discovery institute Calibr and TropIQ Health Sciences report that drugs called isoxa...
Source: TIME: Science - July 2, 2018 Category: Science Authors: Alexandra Sifferlin Tags: Uncategorized healthytime Innovation Health public health Source Type: news

FDA Warns Of Accidental Overdosing Of Dogs
(CBS Local)– The Food and Drug Administration released a statement on its website Friday about a noise aversion drug called Sileo that is causing dogs to accidentally overdose. Sileo is a drug given to dogs to treat noise aversion or signs related to anxiety. Zoetis, the world’s largest producer of medicine and vaccinations for animals, began marketing the drug in May 2016. The FDA reportedly became aware of issues with the drug in 2017, but the problems continued. “In 2017, after becoming aware of the adverse events related to ring-stop locking issues, the FDA asked Zoetis to revise its labeling to ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - June 29, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News FDA Local TV talkers Source Type: news

Polio Virus Could Help Treat Brain Cancer. Here ’s How
The idea that viruses may be co-opted to do good rather than harm isn’t entirely new; researchers have been attempting to harness the power of viruses and bacteria for more than a century. Vaccines are the shining example of using bad bugs to do good in priming the immune system to fight disease. But disease-causing viruses aren’t always easy to corral, and attempts to use them to activate the immune system against things other than fellow bacteria and viruses — including cancer, for example — have not been so successful. There is only one approved virus-based treatment for cancer, which uses herpes...
Source: TIME: Health - June 26, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer healthytime Source Type: news

Combining different malaria vaccines could reduce cases by 91 percent
Using two experimental anti-malarial vaccines can greatly reduce the number of malaria infections in animal studies, according to a research team that includes MRC scientists. (Source: Medical Research Council General News)
Source: Medical Research Council General News - June 20, 2018 Category: Research Source Type: news

Combining different malaria vaccines could reduce cases by 91 percent
(Imperial College London) Using two experimental anti-malarial vaccines, which work in different ways, can greatly reduce the number of malaria infections in animal studies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 19, 2018 Category: International Medicine & Public Health Source Type: news

Yellow fever: A new method for testing vaccine safety
(Institut Pasteur) Scientists from the Institut Pasteur, the CNRS and Sanofi Pasteur have recently developed a novel alternative method to animal testing that can be used to verify the safety of vaccines such as the yellow fever vaccine. This original approach is based on the development of an in cellulo device using a 3D culture model, the 'BBB-Minibrain'. A patent application has been filed by the Institut Pasteur and Inserm. The results of this research were published in the journal Biologicals in May 2018. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 14, 2018 Category: International Medicine & Public Health Source Type: news

A new vaccine and probiotic combat cholera in animal models
(American Association for the Advancement of Science) In a pair of studies, scientists have devised new vaccine-based and probiotic interventions that help prevent severe cholera infections in animal models. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 13, 2018 Category: Infectious Diseases Source Type: news

Test vaccine active against many HIV strains
An experimental HIV vaccine prompted animal immune systems to form antibodies that neutralize dozens of HIV strains. A study of the test vaccine in people is being planned. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - June 12, 2018 Category: Consumer Health News Source Type: news

Human Trials Set for Experimental HIV Vaccine
WEDNESDAY, June 6, 2018 -- An experimental HIV vaccine protected animals from dozens of strains of HIV. And a human trial of the vaccine is expected to begin in the second half of 2019, according to U.S. researchers. The vaccine targets a vulnerable... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 6, 2018 Category: General Medicine Source Type: news

HIV vaccine elicits antibodies in animals that neutralize dozens of HIV strains
NIH study results represent major advance for structure-based HIV vaccine design. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - June 4, 2018 Category: American Health Source Type: news

HIV Vaccine Elicits Antibodies in Animals that Neutralize Dozens of HIV Strains
An experimental vaccine regimen based on the structure of a vulnerable site on HIV elicited antibodies in mice, guinea pigs and monkeys that neutralize dozens of HIV strains from around the world. (Source: PHPartners.org)
Source: PHPartners.org - June 4, 2018 Category: International Medicine & Public Health Source Type: news

Health Officials 'Cautiously Optimistic' on Ebola Response
GENEVA (AP) — The World Health Organization said Tuesday it is "cautiously optimistic" about efforts to curb the spread of Ebola in an urban area in Congo, although the lethal virus is still reported in at least two remote areas. There have been 35 confirmed cases, including 12 deaths. The U.N. health agency and partners have vaccinated more than 400 people with an experimental Ebola vaccine, the first time it has been used in an emerging outbreak. WHO emergencies chief Peter Salama told reporters that the response has gone "quite smoothly" and that the agency's first priority had been to stop Ebo...
Source: JEMS Patient Care - May 29, 2018 Category: Emergency Medicine Authors: Associated Press Tags: Patient Care News Source Type: news

Health Officials 'Cautiously Optimistic' on Ebola Response
GENEVA (AP) — The World Health Organization said Tuesday it is "cautiously optimistic" about efforts to curb the spread of Ebola in an urban area in Congo, although the lethal virus is still reported in at least two remote areas. There have been 35 confirmed cases, including 12 deaths. The U.N. health agency and partners have vaccinated more than 400 people with an experimental Ebola vaccine, the first time it has been used in an emerging outbreak. WHO emergencies chief Peter Salama told reporters that the response has gone "quite smoothly" and that the agency's first priority had been to stop Ebo...
Source: JEMS: Journal of Emergency Medical Services News - May 29, 2018 Category: Emergency Medicine Authors: Associated Press Tags: Patient Care News Source Type: news

Health Officials 'Cautiously Optimistic' on Ebola Response
GENEVA (AP) — The World Health Organization said Tuesday it is "cautiously optimistic" about efforts to curb the spread of Ebola in an urban area in Congo, although the lethal virus is still reported in at least two remote areas. There have been 35 confirmed cases, including 12 deaths. The U.N. health agency and partners have vaccinated more than 400 people with an experimental Ebola vaccine, the first time it has been used in an emerging outbreak. WHO emergencies chief Peter Salama told reporters that the response has gone "quite smoothly" and that the agency's first priority had been to stop Ebo...
Source: JEMS Patient Care - May 29, 2018 Category: Emergency Medicine Authors: Associated Press Tags: Patient Care News Source Type: news